Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeObject Symbol | Species | Term | Qualifier | Evidence | With | Notes | Source | Original Reference(s) | Emca11 | Rat | increased mammary adenocarcinoma incidence | | IDA | | | RGD | | Emca12 | Rat | increased mammary adenocarcinoma incidence | | IDA | | | RGD | | Emca13 | Rat | increased mammary adenocarcinoma incidence | | IDA | | | RGD | | ACI.BN-(D5Mgh17-D5Rat98)/Shul | Rat | increased tumor latency | induced | IAGP | 17 beta-estradiol | compared to treated ACI/SegHsd | RGD | | ACI.BN-(D5Rat113-D5Rat36)/Shul | Rat | increased tumor latency | induced | IAGP | 17 beta-estradiol | compared to treated ACI/SegHsd | RGD | | ACI.BN-(D5Uwm70-D5Mgh15)/Shul | Rat | increased tumor latency | induced | IAGP | 17 beta-estradiol | compared to treated ACI/SegHsd | RGD | | ACI.BN-(D5Mgh17-D5Mgh15)/Shul | Rat | increased tumor latency | induced | IAGP | 17 beta-estradiol | compared to treated ACI/SegHsd | RGD | | ACI.BN-(D5Rat113-D5Rat159)/Shul | Rat | increased tumor latency | induced | IAGP | 17 beta-estradiol | compared to treated ACI/SegHsd | RGD | | ACI.BN-(D5Rat72-D5Rat36)/Shul | Rat | increased tumor latency | induced | IAGP | 17 beta-estradiol | compared to treated ACI/SegHsd | RGD | | |